Price increases in MedTech: How AI can countermeasures against surging inflation

Inflation is no longer a distant threat; it is a present reality that is reshaping the financial landscape across industries, with MedTech companies particularly feeling the pinch.

The rising costs of raw materials, manufacturing, and logistics are squeezing profit margins, forcing companies to confront an uncomfortable truth: without proactive countermeasures, these cost increases will persist, eroding operational income and stifling growth.

The good news? There are strategic actions that can mitigate these impacts, and minimal price adjustments can effectively recoup lost income.